On November 29, 2021, TonBridge Medical’s Flow Diverter has successfully completed the enrollment of the last patient in a national prospective multi-center single-arm clinical trial project.

The clinical trial has made significant progress in less than 5 months since the first case enrollment was launched in July this year, again demonstrating TonBridge Medical’s strong R&D capabilities and efficient execution.